Showing results (111-120 of 370) with videos related to

Sort By:
Pageof 37
Idrugs : the Investigational Drugs Journal|February 4, 2010
XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLCYing Zhang, Fadila Guessous, Alex Kofman, et al.
Neuro-Oncology Practice|May 15, 2023
Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphomaJoy C Zhang, Matthew J Stotts, Bethany Horton, et al.
Journal of Neuro-Oncology|August 30, 2014
Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institutionJacob J Mandel, Shlomit Yust-Katz, David Cachia, et al.
Journal of the Neurological Sciences|May 3, 2015
Adult brainstem gliomas: Correlation of clinical and molecular featuresBrett J Theeler, Benjamin Ellezam, Isaac Melguizo-Gavilanes, et al.
Neuro-Oncology|February 7, 2012
Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumorsTerri S Armstrong, Patrick Y Wen, Mark R Gilbert, et al.
Cureus|February 22, 2021
Encephalomyeloradiculoneuropathy Revealing a Rare Case of Intravascular Large B-Cell LymphomaJehanne Aasfara, Fadila Guessous, Abderahmane Al Bouzidi, et al.
Journal of Neuro-Oncology|February 8, 2012
Subependymal seeding of low-grade oligodendroglial neoplasms: a case seriesManal Nicolasjilwan, M Beatriz Lopes, James Larner, et al.
Journal of Neuro-Oncology|April 1, 2009
Disseminated strongyloidiasis complicating glioblastoma therapy: a case reportDawit Aregawi, David Lopez, Mark Wick, et al.
Nature Clinical Practice. Neurology|November 6, 2007
Surgery Insight: the role of surgery in the management of low-grade gliomasNader Pouratian, Ashok Asthagiri, Jay Jagannathan, et al.
Neurology|December 28, 2020
Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular SubtypeMaria Diaz, Jasmin Jo, Mark Smolkin, et al.
Pageof 37